Adult Vaccines Market to Capture a CAGR of 6.03% While Touching Approximately USD 30 Billion by 2030 – Report by Zion Market Research
August 21, 2023 10:16 ET
|
Zion Market Research
NEW YORK, United States, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Adult Vaccines Market By Vaccine (Varicella, Influenza, Human...
Adult Vaccines Market Report to 2031: Visiongain Research Inc.
July 27, 2021 10:38 ET
|
Visiongain Ltd
Visiongain has published a new report on Adult Vaccines Market Report to 2031: Forecasts By Vaccine (Influenza, Tetanus /Diphtheria/Pertussis, Varicella, Human Papillomavirus, Zoster,...
Visiongain launches report entitled Global Influenza Vaccines - World Industry Market Outlook 2017-2027
July 06, 2017 07:48 ET
|
Visiongain Ltd
LONDON, July 06, 2017 (GLOBE NEWSWIRE) -- Forecasts for Trivalent Influenza Vaccines (TIV) & Quadrivalent Influenza Vaccines (QIV), Analysis of Pipeline Developments For Fluzone / VaxiGrip,...
Blood Banking and Blood Products - Global Strategic Business Report 2017
May 18, 2017 04:57 ET
|
Research and Markets
Dublin, May 18, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Blood Banking and Blood Products - Global Strategic Business Report" report to their...
VALNEVA publie une forte progression de son chiffre d'affaires et un EBITDA positif au S1 2016
August 31, 2016 01:00 ET
|
VALNEVA
Valneva publie une forte progression de son chiffre d'affaires et un EBITDA positif au S1 confirmant l'évolution du Groupe vers l'équilibre opérationnel La performance financière des produits...
VALNEVA Reports Strong Revenue Growth and Positive EBITDA in H12016
August 31, 2016 01:00 ET
|
VALNEVA
Valneva Reports Strong Revenue Growth and Positive EBITDA in H1 Confirming the Company's Trend towards EBITDA Break-even Financial performance of commercial products continued to improve in the...
VALNEVA Announces Signing of Marketing & Distribution Agreement for Seqirus' Flu vaccines Sandovac(R) and Fluad(R) in Austria
August 25, 2016 01:12 ET
|
VALNEVA
LYON, France, Aug. 25, 2016 (GLOBE NEWSWIRE) -- Valneva SE ("Valneva" or "the Company"), a leading pure play vaccine company, today announced the signing of an agreement with Seqirus, the second...
VALNEVA Announces Signing of Marketing & Distribution Agreement for Seqirus' Flu vaccines Sandovac® and Fluad® in Austria
August 25, 2016 01:00 ET
|
VALNEVA
Valneva Announces Signing of Marketing & Distribution Agreement for Seqirus' Flu vaccines Sandovac® and Fluad® in Austria Lyon (France), August 25, 2016 - Valneva SE ("Valneva" or "the...
VALNEVA annonce la signature d'un accord avec Seqirus pour le marketing et la distribution des vaccins contre la grippe Sandovac® et Fluad® en Autriche
August 25, 2016 01:00 ET
|
VALNEVA
Valneva annonce la signature d'un accord avec Seqirus pour le marketing et la distribution des vaccins contre la grippe Sandovac® et Fluad® en Autriche Lyon (France), 25 août 2016 - Valneva SE...
Global Influenza Vaccines and Therapeutics Market 2012-2022 - Market Estimated to be US$6.1 Billion in 2016 and Anticipated to Reach US$10.2 Billion by 2022
August 04, 2016 10:12 ET
|
Research and Markets
Dublin, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Influenza Market - Vaccines and Therapeutics" report to their offering. ...